期刊文献+

食管癌中ICE、Fas、FasL的表达及其意义

Expression and significance of the ICE, Fas and FasL protein in the esophageal carcinoma
暂未订购
导出
摘要 目的了解食管癌组织中的促凋亡状况及其与抗肿瘤免疫的关系。方法采用免疫组化 L SAB法对 4 6例食管癌手术切除标本中的白细胞介素 1β转化酶 (IL- 1β converting enzyme,ICE)、Fas、Fas L 蛋白进行标记 ,并对其中 13例进行 Td T介导d UTP缺口末端标记。结果 ICE、Fas、Fas L蛋白在癌巢中的阳性率分别为 78.2 6 %、6 0 .87%和 4 7.83% ,ICE蛋白的表达程度与癌组织学分级有相关性。结论癌组织表达 Fas、Fas L,可能参与癌细胞的免疫逃避 ;ICE的表达与癌组织分化有一定关系。 ObjectiveTo study the relationship between the antitumor immunoreaction and the cell apoptosis in esophageal carcinoma.MethodsThe IL-1β converting enzyme, Fas and FasL protein were labeled by LSAB immunohistochemistric method in 46 cases of esophageal carcinoma, of which 13 cases were labeled by TdT mediated dUTP nick end labeling (TUNEL).ResultsThe positive rates of ICE, Fas and FasL proteins in the cancer nests were 78.26%, 60.87% and 47.83%. The expression of ICE protein was related to the histological grading of the cancer.Conclusions The expression of Fas, FasL protein may be related to the immunological escape of the cancer cell; the expression of ICE was related to the histological grading of the cancer.
出处 《中国康复理论与实践》 CSCD 2003年第6期344-345,355,共3页 Chinese Journal of Rehabilitation Theory and Practice
关键词 凋亡 食管癌 凋亡相关蛋白 apoptosis esophageal carcinoma apoptosis related protein
  • 相关文献

参考文献8

  • 1Zeytum A, Hassuneh M, Nagarkatti M, et al. Fas-Fas ligand interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street[J]. Blood, 1997,90(5):1952--1956.
  • 2Los M, Van de Graen M, Penning LC, et al. Requirement of an ICE/CED-3 protease for Fas/APO-I mediated apoptosis[J]. Nature, 1995,375(6526) : 81--83.
  • 3Noriko K, Yoshihito G, Hiroyuki S, et al, Apoptotic cell death in human gastric carcinoma;analysis by terminal deoxynuleotidyl transferase-mediated dUTP-biotin nick end labeling[J], Jpn J Cancer Res, 1994,85 (9) ;939--945.
  • 4Robertson LE, Plunkett W, Me Connell K, et al. Bcl-2 epression in choronic lymphocytic loukemia and its correlation with the induction if apoptosis and clinical outcome[J]. Leukemia, 1996,10 : 456--459.
  • 5Golstein DV. Fas and other cell death signaling pathways [J]. Sem Immunol,1997,9(2) :93--107.
  • 6Chinnaiyan AM, Dixit VM. Portait of an executioner: the molecular mechanism of Fas/APO-l-induced apoptosis[J]. Sem Immunol, 1997,9(1) : 69--76.
  • 7O'Connell J, O'Sulliva GC, Collins JK, et al. The Fas counter attack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand[J]. J Exp Med, 1996,184 (2):1075.
  • 8Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor immune escape[J]. Science, 1996,274(5291) : 1363.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部